Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia

Leukemia volume 19, pages 153–154 (2005)Cite this article

TO THE EDITOR

We read with interest the article by Lundin et al1 published in a recent issue of this journal. They studied immune reconstitution after subcutaneous Campath-1H therapy (target dose 30 mg) in previously untreated B-CLL patients. All lymphocyte subsets were significantly reduced during the study period and there was no correlation between the cumulative dose of alemtuzumab and the severity of immunosuppression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lundin J, Porwit-MacDonald A, Rossmann ED, Karlsson C, Edman P, Rezvany MR et al. Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, Campath-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia 2004; 18: 484–490.

    Article  CAS  Google Scholar 

  2. Laurenti L, Piccioni P, Piccirillo N, Sora' F, Chiusolo P, Garzia MG et al. Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in 149 patients' group. Leukemia Lymphoma 2004; 45: 2063–2070.

    Article  Google Scholar 

  3. Fegan C, Thomas H, Bailey-Wood R, Coleman S, Phillips S, Hoy T et al. In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 277–281.

    CAS  PubMed  Google Scholar 

  4. Guillaume T, Rubinstein DB, Symann M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471–1490.

    CAS  Google Scholar 

  5. Laurenti L, Sora F, Piccirillo N, Chiusolo P, Cicconi S, Rutella S et al. Immune reconstitution after autologous selected peripheral blood progenitor cell transplantation: comparison of two CD34+ cell-selection systems. Transfusion 2001; 41: 783–789.

    Article  CAS  Google Scholar 

  6. Rutella S, Rumi C, Laurenti L, Pierelli L, Sora' F, Sica S et al. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105–115.

    Article  CAS  Google Scholar 

  7. Laurenti L, Sica S, Sora F, Piccirillo N, Ortu La Barbera E, Chiusolo P et al. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case–control study. Haematologica 1999; 84: 1100–1103.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Ematologia, Policlinico A Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy

    L Laurenti, P Piccioni, M Tarnani, P Chiusolo, N Piccirillo, C Rumi, F Sora, S Sica & G Leone

Authors
  1. L Laurenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Piccioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Tarnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Chiusolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Piccirillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Rumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Sora
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Sica
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Laurenti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laurenti, L., Piccioni, P., Tarnani, M. et al. Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia. Leukemia 19, 153–154 (2005). https://doi.org/10.1038/sj.leu.2403561

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403561

This article is cited by

Search

Advanced search

Quick links